Literature DB >> 7596489

VV-hemorphin-7 and LVV-hemorphin-7 released during in vitro peptic hemoglobin hydrolysis are morphinomimetic peptides.

I Garreau1, Q Zhao, C Pejoan, A Cupo, J M Piot.   

Abstract

Two opioid peptides were generated by in vitro pepsin treatment of bovine hemoglobin. These peptides were identified using a GPI test and purified using HPLC chromatographic techniques. They correspond to fragments 31-40 (LVV-hemorphin-7) and 32-40 (VV-hemorphin-7) of the beta-chain of bovine hemoglobin. Binding experiments strongly confirm that VV-hemorphin-7 and LVV-hemorphin-7 are opioid peptides since they inhibited [3H]naloxone binding to rat brain membranes. Our results indicate that VV-hemorphin-7 and LVV-hemorphin-7 exhibit a lesser potency both in GPI and binding tests. Selectivity and affinity of these purified peptides and synthetic hemorphin-7 for opioid receptors is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596489     DOI: 10.1016/0143-4179(95)90028-4

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  10 in total

1.  Hemorphins act as homeostatic agents in response to endotoxin-induced stress.

Authors:  Nina Barkhudaryan; Hermine Zakaryan; Flora Sarukhanyan; Anna Gabrielyan; Dominik Dosch; Josef Kellermann; Friedrich Lottspeich
Journal:  Neurochem Res       Date:  2009-12-05       Impact factor: 3.996

2.  LVV-hemorphin-4 modulates Ca2+/calmodulin-dependent pathways in the immune system by the same mechanism as in the brain.

Authors:  Nina Barkhudaryan; Spartak Gambarov; Tadevos Gyulbayazyan; Karine Nahapetyan
Journal:  J Mol Neurosci       Date:  2002-06       Impact factor: 3.444

3.  Mass spectrometry screening reveals peptides modulated differentially in the medial prefrontal cortex of rats with disparate initial sensitivity to cocaine.

Authors:  Elena V Romanova; Ji Eun Lee; Neil L Kelleher; Jonathan V Sweedler; Joshua M Gulley
Journal:  AAPS J       Date:  2010-05-19       Impact factor: 4.009

4.  Positive Modulation of Angiotensin II Type 1 Receptor-Mediated Signaling by LVV-Hemorphin-7.

Authors:  Amanat Ali; Abdulrasheed Palakkott; Arshida Ashraf; Isra Al Zamel; Bincy Baby; Ranjit Vijayan; Mohammed Akli Ayoub
Journal:  Front Pharmacol       Date:  2019-10-25       Impact factor: 5.810

Review 5.  Hemorphins Targeting G Protein-Coupled Receptors.

Authors:  Mohammed Akli Ayoub; Ranjit Vijayan
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-07

6.  Explorative Screening of Bioactivities Generated by Plant-Based Proteins after In Vitro Static Gastrointestinal Digestion.

Authors:  Camille Dugardin; Benoit Cudennec; Mélissa Tourret; Juliette Caron; Laetitia Guérin-Deremaux; Josette Behra-Miellet; Catherine Lefranc-Millot; Rozenn Ravallec
Journal:  Nutrients       Date:  2020-12-05       Impact factor: 5.717

Review 7.  Dysregulation in erythrocyte dynamics caused by SARS-CoV-2 infection: possible role in shuffling the homeostatic puzzle during COVID-19.

Authors:  Michelle Mendanha Mendonça; Kellen Rosa da Cruz; Denise da Silva Pinheiro; Gean Carlos Alves Moraes; Patricia Maria Ferreira; Marcos Luiz Ferreira-Neto; Eduardo Sérgio da Silva; Reggiani Vilela Gonçalves; Gustavo Rodrigues Pedrino; James O Fajemiroye; Carlos Henrique Xavier
Journal:  Hematol Transfus Cell Ther       Date:  2022-01-25

Review 8.  Hemorphins-From Discovery to Functions and Pharmacology.

Authors:  Przemyslaw Mielczarek; Kinga Hartman; Anna Drabik; Hao-Yuan Hung; Eagle Yi-Kung Huang; Ewa Gibula-Tarlowska; Jolanta H Kotlinska; Jerzy Silberring
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

9.  Food-Derived Hemorphins Cross Intestinal and Blood-Brain Barriers In Vitro.

Authors:  Dorothée Domenger; Benoit Cudennec; Mostafa Kouach; Véronique Touche; Christophe Landry; Jean Lesage; Fabien Gosselet; Sophie Lestavel; Jean-François Goossens; Pascal Dhulster; Rozenn Ravallec
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-10       Impact factor: 5.555

10.  Camel Hemorphins Exhibit a More Potent Angiotensin-I Converting Enzyme Inhibitory Activity than Other Mammalian Hemorphins: An In Silico and In Vitro Study.

Authors:  Amanat Ali; Seham Abdullah Rashed Alzeyoudi; Shamma Abdulla Almutawa; Alya Nasir Alnajjar; Yusra Al Dhaheri; Ranjit Vijayan
Journal:  Biomolecules       Date:  2020-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.